UNIVERSAL MEDICAL SUPPLIES ApS
CVR number: 35030638
Skovbakken 102, 3520 Farum
info@umss.dk
tel: 69664040
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 569.45 | 2 576.28 | 1 228.83 | 2 239.50 | 2 903.91 |
| Employee benefit expenses | -85.91 | - 263.46 | - 582.63 | -1 175.38 | -2 347.90 |
| Total depreciation | -0.74 | -2.97 | -2.97 | -2.97 | |
| EBIT | 1 483.54 | 2 312.08 | 643.22 | 1 061.15 | 553.04 |
| Other financial expenses | -3.54 | -6.89 | -27.40 | -22.69 | -19.00 |
| Pre-tax profit | 1 480.00 | 2 305.19 | 615.82 | 1 038.46 | 534.04 |
| Income taxes | - 325.59 | - 506.53 | - 133.73 | - 229.14 | - 118.56 |
| Net earnings | 1 154.41 | 1 798.66 | 482.09 | 809.32 | 415.48 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 14.12 | 11.15 | 8.18 | 5.20 | |
| Tangible assets total | 14.12 | 11.15 | 8.18 | 5.20 | |
| Other receivables | 18.00 | 18.54 | 20.19 | ||
| Investments total | 18.00 | 18.54 | 20.19 | ||
| Long term receivables total | |||||
| Finished products/goods | 535.35 | 1 565.28 | 1 491.89 | 872.51 | 1 505.77 |
| Advance payments | 738.37 | 433.14 | 352.17 | 53.97 | 503.06 |
| Inventories total | 1 273.72 | 1 998.42 | 1 844.06 | 926.49 | 2 008.83 |
| Current trade debtors | 349.69 | 30.13 | 470.09 | 435.65 | 833.61 |
| Current amounts owed by group member comp. | 3.05 | 606.25 | 110.54 | ||
| Prepayments and accrued income | 11.03 | 11.49 | 12.32 | 14.40 | 32.21 |
| Current other receivables | 1 000.26 | 0.65 | 0.60 | ||
| Short term receivables total | 363.76 | 1 648.13 | 483.05 | 560.59 | 866.43 |
| Cash and bank deposits | 521.95 | 782.41 | 866.28 | 1 897.87 | 957.93 |
| Cash and cash equivalents | 521.95 | 782.41 | 866.28 | 1 897.87 | 957.93 |
| Balance sheet total (assets) | 2 159.43 | 4 443.08 | 3 222.55 | 3 411.66 | 3 858.58 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 500.00 | 1 500.00 | 1 300.00 | ||
| Retained earnings | - 280.05 | - 625.64 | 1 173.02 | 355.12 | 1 164.43 |
| Profit of the financial year | 1 154.41 | 1 798.66 | 482.09 | 809.32 | 415.48 |
| Shareholders equity total | 1 454.36 | 2 753.02 | 1 735.12 | 2 544.43 | 1 659.92 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 15.41 | ||||
| Advances received | 144.47 | ||||
| Current trade creditors | 30.00 | 30.00 | 71.20 | 124.00 | 106.91 |
| Current owed to participating | 1.78 | ||||
| Current owed to group member | 858.15 | 892.16 | |||
| Short-term deferred tax liabilities | 323.29 | 506.53 | 133.73 | 229.14 | 118.56 |
| Other non-interest bearing current liabilities | 351.78 | 1 153.53 | 424.35 | 514.08 | 919.37 |
| Current liabilities total | 705.07 | 1 690.06 | 1 487.43 | 867.23 | 2 198.66 |
| Balance sheet total (liabilities) | 2 159.43 | 4 443.08 | 3 222.55 | 3 411.66 | 3 858.58 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.